期刊文献+

Transplantation of neonatal cardiomyocytes plus fibrin sealant restores myocardial function in a rat model of myocardial infarction 被引量:4

Transplantation of neonatal cardiomyocytes plus fibrin sealant restores myocardial function in a rat model of myocardial infarction
原文传递
导出
摘要 Background Most cardiac regenerative approaches can restore injured heart muscles. In this study, we investigated if fibrin sealant could help neonatal cardiomyocytes restore myocardial function in a rat model of myocardial infarction. Methods The left anterior descending artery in adult female Sprague-Dawley (SD) rats was ligated to make a myocardial infarction model. Neonatal ventricular cardiomyocytes from one-day male SD rats were isolated, labeled and cultured. The cells were injected into the infarcted area three weeks later. The animals were randomized into four recipient groups: (1) cardiomyocytes plus fibrin sealant (group CF, n=10); (2) cardiomyocytes alone (group C, n=10); (3) fibrin sealant recipients alone (group F, n=10); (4) control group (n=10). Four weeks after transplantation, echocardiography and Langerdoff model were used to assess heart function. Immunohistochemical staining and polymerase chain reaction (PCR) were performed to track the implanted cardiomyocytes and detect the sex-determining region Y gene on Y chromosome. Results Echocardiography showed the fraction shortening (FS) in groups CF, C, F and control group was (27.80±6.32)%, (22.29±4.54)%, (19.24±6.29)% and (20.36±3.29)% respectively with statistically significant differences in group CF compared with the other groups (P〈0.05). The Langendoff model revealed that the left ventricular development of peak pressure (LVDPmax, mmHg) in groups CF, C, F and control group was 104.81±17.05, 80.97±21.60, 72.07±26.17 and 71.42±17.55 respectively with statistically significant differences in group CF compared with the other groups (P〈0.05). Pathological examination and PCR indicated that transplanted cardiomyocytes in group CF survived better than those in the other groups. Conclusion Transplanted neonatal cardiomyocytes plus fibrin sealant can survive in myocardial infarctioned area and improve heart function greatly in rat models. Background Most cardiac regenerative approaches can restore injured heart muscles. In this study, we investigated if fibrin sealant could help neonatal cardiomyocytes restore myocardial function in a rat model of myocardial infarction. Methods The left anterior descending artery in adult female Sprague-Dawley (SD) rats was ligated to make a myocardial infarction model. Neonatal ventricular cardiomyocytes from one-day male SD rats were isolated, labeled and cultured. The cells were injected into the infarcted area three weeks later. The animals were randomized into four recipient groups: (1) cardiomyocytes plus fibrin sealant (group CF, n=10); (2) cardiomyocytes alone (group C, n=10); (3) fibrin sealant recipients alone (group F, n=10); (4) control group (n=10). Four weeks after transplantation, echocardiography and Langerdoff model were used to assess heart function. Immunohistochemical staining and polymerase chain reaction (PCR) were performed to track the implanted cardiomyocytes and detect the sex-determining region Y gene on Y chromosome. Results Echocardiography showed the fraction shortening (FS) in groups CF, C, F and control group was (27.80±6.32)%, (22.29±4.54)%, (19.24±6.29)% and (20.36±3.29)% respectively with statistically significant differences in group CF compared with the other groups (P〈0.05). The Langendoff model revealed that the left ventricular development of peak pressure (LVDPmax, mmHg) in groups CF, C, F and control group was 104.81±17.05, 80.97±21.60, 72.07±26.17 and 71.42±17.55 respectively with statistically significant differences in group CF compared with the other groups (P〈0.05). Pathological examination and PCR indicated that transplanted cardiomyocytes in group CF survived better than those in the other groups. Conclusion Transplanted neonatal cardiomyocytes plus fibrin sealant can survive in myocardial infarctioned area and improve heart function greatly in rat models.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2007年第22期2022-2027,共6页 中华医学杂志(英文版)
关键词 TRANSPLANTATION myocytes cardiac myocardial infarction cell regeneration fibrin sealant transplantation myocytes, cardiac myocardial infarction cell regeneration fibrin sealant
  • 相关文献

参考文献10

  • 1MacIntyre K,Capewell S,Stewart S,et al.Evidence of improv-ing prognosis in heart failure:trends in case fatality in 66 547patients hospitalized between 1986 and 1995[].Circulation.2000
  • 2Kehat,I.,Kenyagin-Karsenti,D.,Snir,M.,Segev,H.,Amit,M.,Gepstein,A.,Livne,E.,Binah,O.,Itskovitz-Eldor,J.,Gepstein,L.Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes[].The Journal of Clinical Investigation.2001
  • 3Mummery,C.,Ward-van Oostwaard,D.,Doevendans,P.,Spijker,R.,van den,Brink,S.,Hassink,R.,van der,Heyden,M.,Opthof,T.,Pera,M.,de,la Riviere,A. B.,Passier,R.,Tertoolen,L.Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells[].Circulation.2003
  • 4Xu C,Police S,Rao N,Carpenter MK.Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells[].Circulation Research.2002
  • 5Dimmeler S,Zeiher AM,Schneider MD.Unchain my heart:the scientific foundations of cardiac repair[].The Journal of Clinical Investigation.2005
  • 6Laflamme MA,Murry CE.Regenerating the heart[].Nature Biotechnology.2005
  • 7Schachinger,V,Assmus,B,Britten,MB,Honold,J,Lehmann,R,Teupe,C,Abolmaali,ND,Vogl,TJ,Hofmann,WK,Martin,H,Dimmeler,S,Zeiher,AM.Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial[].Journal of the American College of Cardiology.2004
  • 8Wollert,K. C.,Meyer,G. P.,Lotz,J.,Ringes-Lichtenberg,S.,Lippolt,P.,Breidenbach,C.,Fichtner,S.,Korte,T.,Hornig,B.,Messinger,D.,Arseniev,L.,Hertenstein,B.,Ganser,A.,Drexler,H.Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial[].The Lancet.2004
  • 9Lunde,K,Solheim,S,Aakhus,S,Arnesen,H,Abdelnoor,M,Egeland,T,Endresen,K,Ilebekk,A,Mangschau,A,Fjeld,JG,Smith,HJ,Taraldsrud,E,Grogaard,HK,Bjornerheim,R,Brekke,M,Muller,C,Hopp,E,Ragnarsson,A,Brinchmann,JE,Forfang,K.Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction[].The New England Journal of Medicine.2006
  • 10Janssens,S,Dubois,C,Bogaert,J,Theunissen,K,Deroose,C,Desmet,W.Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial[].The Lancet.2006

同被引文献12

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部